+Compare
JNJ
Stock ticker:
NYSE
AS OF
Sep 23 closing price
Price
$166.93
Change
+$0.81 (+0.49%)
Capitalization
438.34B

JNJ Price Prediction, Johnson & Johnson AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
GET INTRADAY SIGNALS
JNJ Trading results, last 6 months
AI Robots NameP/L
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Sep 23, 2022

JNJ in upward trend: price may ascend as a result of having broken its lower Bollinger Band on August 31, 2022

JNJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 37 cases where JNJ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 57%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where JNJ's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 22, 2022. You may want to consider a long position or call options on JNJ as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JNJ just turned positive on September 07, 2022. Looking at past instances where JNJ's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where JNJ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for JNJ entered a downward trend on September 22, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.741) is normal, around the industry mean (5.173). P/E Ratio (24.272) is within average values for comparable stocks, (90.169). Projected Growth (PEG Ratio) (3.638) is also within normal values, averaging (3.089). Dividend Yield (0.026) settles around the average of (0.029) among similar stocks. P/S Ratio (4.660) is also within normal values, averaging (3.618).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

JNJ is expected to report earnings to fall 2.32% to $2.53 per share on October 18

Johnson & Johnson JNJ Stock Earnings Reports
Q3'22
Est.
$2.53
Q2'22
Beat
by $0.05
Q1'22
Beat
by $0.08
Q4'21
Beat
by $0.01
Q3'21
Beat
by $0.25
The last earnings report on July 19 showed earnings per share of $2.59, beating the estimate of $2.54. With 9.59M shares outstanding, the current market capitalization sits at 438.34B.
AI
A.I.Advisor
published Dividends

JNJ paid dividends on September 06, 2022

Johnson & Johnson JNJ Stock Dividends
А dividend of $1.13 per share was paid with a record date of September 06, 2022, and an ex-dividend date of August 22, 2022. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 71.41B. The market cap for tickers in the group ranges from 226K to 438.34B. JNJ holds the highest valuation in this group at 438.34B. The lowest valued company is NEWG at 226K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -12%. RHHVF experienced the highest price growth at 3%, while GIFLF experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was 51% and the average quarterly volume growth was 15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 19
P/E Growth Rating: 41
Price Growth Rating: 65
SMR Rating: 41
Profit Risk Rating: 69
Seasonality Score: -18 (-100 ... +100)
AI
View a ticker or compare two or three
JNJ
Buy/Sell Ratings
 
 
Technical Analysis# Of IndicatorsAvg. Odds
   
   
 
AI
A.I. Advisor
published General Information

General Information

an investment holding company with interests in health care products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
One Johnson and Johnson Plaza
Phone
+1 732 524-0400
Employees
141700
Web
https://www.jnj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UG12.240.15
+1.28%
United-Guardian
TFC44.34-0.46
-1.03%
Truist Financial Corp
SGHT6.61-0.07
-1.05%
Sight Sciences
FNB11.78-0.20
-1.67%
FNB Corp
EAT25.53-1.35
-5.02%
Brinker International

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with LLY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.32%
LLY - JNJ
54%
Loosely correlated
+0.19%
AMGN - JNJ
53%
Loosely correlated
-0.34%
ABBV - JNJ
51%
Loosely correlated
+0.03%
BMY - JNJ
47%
Loosely correlated
-0.81%
GILD - JNJ
44%
Loosely correlated
-1.43%
More